| Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study A Bettiol, ML Urban, L Dagna, V Cottin, F Franceschini, S Del Giacco, ... Arthritis & Rheumatology 74 (2), 295-306, 2022 | 96 | 2022 |
| Eosinophilic granulomatosis with polyangiitis: dissecting the pathophysiology F Fagni, F Bello, G Emmi Frontiers in Medicine 8, 627776, 2021 | 73 | 2021 |
| Type I interferon–related kidney disorders L Lodi, MV Mastrolia, F Bello, GM Rossi, ML Angelotti, YJ Crow, ... Kidney international 101 (6), 1142-1159, 2022 | 26 | 2022 |
| Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study A Bettiol, ML Urban, F Bello, D Fiori, I Mattioli, G Lopalco, F Iannone, ... Annals of the Rheumatic Diseases, 2022 | 14 | 2022 |
| Biologics for eosinophilic granulomatosis with polyangiitis M Caminati, M Maule, F Bello, G Emmi Current opinion in allergy and clinical immunology 23 (1), 36-43, 2023 | 10 | 2023 |
| Antiarrhythmic efficacy of anakinra in a young patient with autoimmune lymphocytic myocarditis F Bello, A Marchi, D Prisco, I Olivotto, G Emmi Rheumatology 59 (11), e88-e90, 2020 | 9 | 2020 |
| At the heart of eosinophilic granulomatosis with polyangiitis: into cardiac and vascular involvement M Bond, F Fagni, M Moretti, F Bello, A Egan, A Vaglio, G Emmi, C Dejaco Current Rheumatology Reports 24 (11), 337-351, 2022 | 8 | 2022 |
| Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group M Caminati, A Fassio, F Alberici, C Baldini, F Bello, P Cameli, E Conticini, ... Allergy 79 (2), 516-519, 2024 | 5 | 2024 |
| Gut microbiota and associated mucosal immune response in eosinophilic granulomatosis with polyangiitis (EGPA) E Niccolai, A Bettiol, S Baldi, E Silvestri, L Di Gloria, F Bello, G Nannini, ... Biomedicines 10 (6), 1227, 2022 | 5 | 2022 |
| Eosinophilic granulomatosis with polyangiitis-related myocarditis during mepolizumab therapy reveals a Th1/Th17-mediated vasculitic response F Bello, G Emmi, C Tamburini, L Maggi, F Annunziato, L Cosmi, D Prisco Clinical and experimental rheumatology 40 (4), 863-864, 2022 | 5 | 2022 |
| Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study A Bettiol, ML Urban, R Padoan, M Groh, G Lopalco, A Egan, V Cottin, ... The Lancet Rheumatology 5 (12), e707-e715, 2023 | 4 | 2023 |
| The uncertain meaning of ANCA positivity in IgG4-related disease F Bello Rheumatology 60 (8), 3492-3493, 2021 | 4 | 2021 |
| Evidence of subclinical atherosclerosis in eosinophilic granulomatosis with polyangiitis F Bello, A Bettiol, E Silvestri, I Mattioli, ML Urban, A Palermo, M Mazzetti, ... Rheumatology 62 (2), 835-840, 2023 | 3 | 2023 |
| Microarray evaluation of allergen-specific IgE in eosinophilic granulomatosis with polyangiitis F Bello, F Maritati, A Radice, RA Sinico, G Emmi, A Vaglio Annals of the Rheumatic Diseases 80 (9), 1247-1248, 2021 | 3 | 2021 |
| Nasal Deformity in Granulomatosis with Polyangiitis. F Bello, F Fagni The New England Journal of Medicine 382 (10), 951-951, 2020 | 2 | 2020 |
| Effectiveness and safety of IL1 inhibition with anakinra in chronic refractory idiopathic myocarditis D Malandrino, F Bello, G Lopalco, L Cantarini, I Olivotto, G Emmi, D Prisco Internal and Emergency Medicine, 1-6, 2023 | 1 | 2023 |
| Prevalence and clinical associations of ultrasound-confirmed enthesitis in systemic lupus erythematosus F Fagni, A Bettiol, E Silvestri, R Fedi, A Palermo, ML Urban, R Mazzotta, ... Rheumatology 62 (11), 3619-3626, 2023 | 1 | 2023 |
| OPEN ACCESS EDITED BY GG Loscocco, F Bello, F Mannelli, OW Bjerrum, GN Thomsen, ... Myeloproliferative Neoplasms: Biology and Treatment 3, 27, 2024 | | 2024 |
| Combing through museum collections. A “museomic” application of ZooMS A Monticone, E Panero, E Heritier, B Pergolizzi, FD Bello, E Mecarelli, ... International Journal of Osteoarchaeology, e3295, 2024 | | 2024 |
| P84 Regular monitoring of anti-C1q antibodies can be of help to predict lupus nephritis (LN) exacerbations M Calatroni, E Conte, F Bello, M Stella, F Reggiani, G Moroni Lupus Science & Medicine 11 (Suppl 1), 2024 | | 2024 |
